EHI
GH icon

Eagle Health Investments’s Guardant Health GH Stock Holding History

Eagle Health Investments’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.7M Buy
310,281
+26,181
+9% +$2.63M 5.01% 5
2025
Q4 		$29M Hold
284,100
– – 6.38% 6
2025
Q3 		$17.8M Buy
284,100
+72,100
+34% +$3.92M 4.66% 9
2025
Q2 		$11M Buy
+212,000
New +$9.47M 2.72% 16
2024
Q3 		– Sell
-626,909
Closed -$18.1M – 26
2024
Q2 		$18.1M Sell
626,909
-103,300
-14% -$2.41M 3.18% 16
2024
Q1 		$15.1M Buy
730,209
+610,100
+508% +$13.1M 2.8% 12
2023
Q4 		$3.25M Sell
120,109
-84,752
-41% -$2.22M 0.66% 20
2023
Q3 		$6.07M Sell
204,861
-240,300
-54% -$8.45M 1.34% 19
2023
Q2 		$15.9M Sell
445,161
-151,400
-25% -$4.35M 2.98% 16
2023
Q1 		$14M Buy
596,561
+530,001
+796% +$15.1M 2.72% 16
2022
Q4 		$1.81M Sell
66,560
-85,400
-56% -$3.91M 0.42% 20
2022
Q3 		$8.18M Hold
151,960
– – 1.88% 19
2022
Q2 		$6.13M Hold
151,960
– – 1.43% 21
2022
Q1 		$10.1M Buy
151,960
+32,600
+27% +$2.23M 2.48% 19
2021
Q4 		$11.9M Buy
119,360
+23,700
+25% +$2.45M 2.91% 19
2021
Q3 		$12M Buy
95,660
+67,400
+238% +$8.01M 3.79% 14
2021
Q2 		$3.51M Hold
28,260
– – 1.2% 22
2021
Q1 		$4.31M Sell
28,260
-4,200
-13% -$635K 1.69% 20
2020
Q4 		$4.18M Buy
+32,460
New +$3.73M 2.68% 16

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eagle Health Investments's GH Position: Q1 2026 in Review

Eagle Health Investments increased its Guardant Health (GH) stake by 9.2% in Q1 2026, buying an estimated $2.63M and bringing the position to 310,281 shares worth $28.7M. The position accounts for 5.01% of the portfolio, ranked #5.

Eagle Health Investments first reported a position in GH in Q4 2020 and has held it in 19 quarters since. The position peaked at $29M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Eagle Health Investments held 310,281 shares of Guardant Health worth $28.7M as of Q1 2026.
  • Eagle Health Investments bought 26,181 Guardant Health shares in Q1 2026, an estimated $2.63M.
  • Guardant Health made up 5.01% of Eagle Health Investments's portfolio in Q1 2026, its #5 holding.
  • Eagle Health Investments first reported a position in Guardant Health in Q4 2020 and has held it in 19 quarters since.
  • Eagle Health Investments's Guardant Health position peaked at $29M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Eagle Health Investments's 13F filing for Q1 2026, filed 15 May 2026.